These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 27775829)
1. Approved and Experimental Small-Molecule Oncology Kinase Inhibitor Drugs: A Mid-2016 Overview. Fischer PM Med Res Rev; 2017 Mar; 37(2):314-367. PubMed ID: 27775829 [TBL] [Abstract][Full Text] [Related]
2. Properties of FDA-approved small molecule protein kinase inhibitors. Roskoski R Pharmacol Res; 2019 Jun; 144():19-50. PubMed ID: 30877063 [TBL] [Abstract][Full Text] [Related]
3. Quantitative proteomics of kinase inhibitor targets and mechanisms. Daub H ACS Chem Biol; 2015 Jan; 10(1):201-12. PubMed ID: 25474541 [TBL] [Abstract][Full Text] [Related]
4. A historical overview of protein kinases and their targeted small molecule inhibitors. Roskoski R Pharmacol Res; 2015 Oct; 100():1-23. PubMed ID: 26207888 [TBL] [Abstract][Full Text] [Related]
5. Leveraging Structural Diversity and Allosteric Regulatory Mechanisms of Protein Kinases in the Discovery of Small Molecule Inhibitors. Verkhivker GM Curr Med Chem; 2017; 24(42):4838-4872. PubMed ID: 27719654 [TBL] [Abstract][Full Text] [Related]
6. 25 years of small molecular weight kinase inhibitors: potentials and limitations. Fabbro D Mol Pharmacol; 2015 May; 87(5):766-75. PubMed ID: 25549667 [TBL] [Abstract][Full Text] [Related]
7. The design, annotation, and application of a kinase-targeted library. Xi H; Lunney EA Methods Mol Biol; 2011; 685():279-91. PubMed ID: 20981529 [TBL] [Abstract][Full Text] [Related]
8. Small molecule kinase inhibitors as anti-cancer therapeutics. Chahrour O; Cairns D; Omran Z Mini Rev Med Chem; 2012 May; 12(5):399-411. PubMed ID: 22303944 [TBL] [Abstract][Full Text] [Related]
9. Selective and potent small-molecule inhibitors of PI3Ks. Jeong Y; Kwon D; Hong S Future Med Chem; 2014 May; 6(7):737-56. PubMed ID: 24941870 [TBL] [Abstract][Full Text] [Related]
10. Advances of small molecule targeting of kinases. Berndt N; Karim RM; Schönbrunn E Curr Opin Chem Biol; 2017 Aug; 39():126-132. PubMed ID: 28732278 [TBL] [Abstract][Full Text] [Related]
11. Recent advances in the discovery of small molecule c-Met Kinase inhibitors. Parikh PK; Ghate MD Eur J Med Chem; 2018 Jan; 143():1103-1138. PubMed ID: 29157685 [TBL] [Abstract][Full Text] [Related]
12. Small molecule modulators targeting protein kinase CK1 and CK2. Qiao Y; Chen T; Yang H; Chen Y; Lin H; Qu W; Feng F; Liu W; Guo Q; Liu Z; Sun H Eur J Med Chem; 2019 Nov; 181():111581. PubMed ID: 31400711 [TBL] [Abstract][Full Text] [Related]
13. Prospects for pharmacological targeting of pseudokinases. Kung JE; Jura N Nat Rev Drug Discov; 2019 Jul; 18(7):501-526. PubMed ID: 30850748 [TBL] [Abstract][Full Text] [Related]
14. A structural atlas of kinases inhibited by clinically approved drugs. Wang Q; Zorn JA; Kuriyan J Methods Enzymol; 2014; 548():23-67. PubMed ID: 25399641 [TBL] [Abstract][Full Text] [Related]
15. Design of targeted libraries against the human Chk1 kinase using PGVL Hub. Peng Z; Hu Q Methods Mol Biol; 2011; 685():321-36. PubMed ID: 20981531 [TBL] [Abstract][Full Text] [Related]
16. Small molecule substrate phosphorylation site inhibitors of protein kinases: approaches and challenges. Breen ME; Soellner MB ACS Chem Biol; 2015 Jan; 10(1):175-89. PubMed ID: 25494294 [TBL] [Abstract][Full Text] [Related]
17. Fluorescence labels in kinases: a high-throughput kinase binding assay for the identification of DFG-out binding ligands. Simard JR; Rauh D Methods Mol Biol; 2012; 800():95-117. PubMed ID: 21964785 [TBL] [Abstract][Full Text] [Related]